| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $98.83M | $107.05M | $100.75M | $57.60M | $54.93M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | -$98.69M | -$106.78M | -$100.29M | -$56.83M | -$44.11M |
| Interest Expense | $57.44M | $62.76M | $58.74M | $31.88M | $19.77M |
| Tax Expense | $6.00K | $155.00K | $31.00K | -$326.00K | $1.73M |
| Net Income | $34.51M | $73.65M | $83.84M | $15.54M | $83.63M |
| EPS (basic) | 1.8100 | 2.4000 | 2.3000 | 1.9300 | 1.6700 |
| EPS (diluted) | 1.8100 | 2.4000 | 2.3000 | 1.9300 | 1.6700 |
| Shares (diluted) | $37.04M | $37.06M | $35.93M | $30.89M | $28.48M |